Clinical Program

$627,478P01FY2013CANIH

University Of California, San Diego, La Jolla CA

Investigators

Linked publications, trials & patents

Paper 35230971 Paper 34686499 Paper 34285341 Paper 33714981 Paper 33689703 Paper 33627156 Paper 33615197 Paper 33604581 Paper 33451349 Paper 33081820 Paper 31723042 Paper 31543463 Paper 31292113 Paper 31204237 Paper 31142838 Paper 30967392 Paper 30923040 Paper 30821551 Paper 30712845 Paper 30622177 Paper 30575108 Paper 30568170 Paper 30503705 Paper 30282833 Paper 30242085 Paper 29880603 Paper 29872501 Paper 29859176 Paper 29752258 Paper 29678828 Paper 29263891 Paper 28972595 Paper 28971726 Paper 28923920 Paper 28835371 Paper 28737232 Paper 28526063 Paper 28515090 Paper 28491097 Paper 28465529 Paper 28465528 Paper 28412730 Trial NCT01253460 Trial NCT00265915 Patent 9938350 Patent 9758591 Patent 9480699 Patent 9242014 Patent 9217040 Patent 9051618 Patent 9044474 Patent 9023598 Patent 9017940 Patent 9017939 Patent 9006190 Patent 8911936 Patent 8883749 Patent 8865885 Patent 8658370 Patent 8658362 Patent 8603744 Patent 8580500 Patent 8557520 Patent 8557515 Patent 8530159 Patent 8526583 Patent 8518647 Patent 8512951 Patent 8507202 Patent 8492083 Patent 8486913 Patent 8486912 Patent 8481505 Patent 8431342 Patent 8389210 Patent 8377637 Patent 8361710 Patent 8354229 Patent 8354224 Patent 8349568 Patent 8343725 Patent 8338106 Patent 8338105 Patent 8338104 Patent 8338103 Patent 8338102 Patent 8212009 Patent 8148069 Patent 8084199 Patent 8071315 Patent 8071292 Patent 8034560 Patent 7985584 Patent 7943318 Patent 7723035 Patent 7670840 Patent 7667090 Patent 7601846 Patent 6841565 Patent 6696441

Abstract

PROJECT SUIVIMARY (See instructions):' Core D provides the platform and infrastructure in which CRC investigators at multiple institutions develop, implement, execute, monitor, and analyze CRC clinical and laboratory data from subjects treated on clinical trials and enrolled in the CRC Tissue Bank. Furthermore, the investigators of Core D will identify and develop clinical research strategies utilizing new agents and combinations, with the ultimate goal of curing CLL. A primary objective of Core D is to provide indispensable clinical input and focus for collection and management of clinical data for CRC Projects and Tissue Bank. A web-based CRC Integrated Information Management System(CIMS) was developed in collaboration with the CRC Biomedical Informatics (CBMI) Workgroup. This system was designed to collect and manage clinical and laboratory information for patients samples stored in the CRC Tissue Bank and for patients treated on CRC clinical trials. This system enables collection of clinical and laboratory information from each CRC site via the Internet in real-time. Current and proposed efforts will be to transition to automated methods of data collection. Clinical research based objectives will utilize clinical and laboratory information to develop new prognostic models, treatments and treatment objectives for patients with CLL. Core D will assure accurate and complete data collection for the following purposes; reports patient scheduling/calendaring; data exports that facilitate analyses and reporting; and patient data monitoring and auditing and assuring regulatory and sponsor compliance required by each CRC clinical trial. Since last funding, the CRC has complete 5 clinical studies which are published, in follow-up, or in manuscript preparation. The CRC currently has 4 active clinical trials as detailed in this Core D write-up. Finally, there are 14 clinical trials in development as described in this Core D write-up and in each Project description throughout the grant application. Because there are circulating tumor cells that can be easily and readily accessed and given the scientific quality of CRC Project investigators, the CRC is uniquely positioned to do detailed correlative studies for patients treated on clinical trial in order to address mechanism of action questions and hypotheses testing and confirmation.

View original record on NIH RePORTER →